PRESS RELEASESNeurocrine Biosciences Announces Conference Call And Webcast Of Second Quarter 2020 Financial ResultsBy PR NewswireJul 13, 2020 4:01 PM EDT
PRESS RELEASESNeurocrine Biosciences And Takeda Announce Collaboration To Develop And Commercialize Potential Therapies For Psychiatric DisordersBy Business WireJun 16, 2020 7:00 AM EDT
PRESS RELEASESNeurocrine Biosciences To Present At The Bank Of America Securities 2020 Napa Biopharma ConferenceBy PR NewswireJun 15, 2020 4:01 PM EDT
PRESS RELEASESNeurocrine Biosciences To Present At The Goldman Sachs 41st Annual Global Healthcare Conference WebcastBy PR NewswireJun 4, 2020 4:01 PM EDT
PRESS RELEASESNeurocrine Biosciences To Present At The Jefferies Virtual Healthcare ConferenceBy PR NewswireMay 26, 2020 4:01 PM EDT
PRESS RELEASESNeurocrine Biosciences To Present At The RBC Capital Markets 2020 Global Healthcare ConferenceBy PR NewswireMay 14, 2020 7:29 PM EDT
PRESS RELEASESNeurocrine Biosciences Exercises Option To License Idorsia's Novel Treatment For Rare Pediatric EpilepsyBy PR NewswireMay 11, 2020 4:01 PM EDT
PRESS RELEASESNeurocrine Biosciences To Present At Bank Of America Merrill Lynch Health Care Conference 2020By PR NewswireMay 5, 2020 4:01 PM EDT
PRESS RELEASESNeurocrine Biosciences Announces FDA Approval Of Once-Daily ONGENTYS® (opicapone) As An Add-On Treatment For Patients With Parkinson's Disease Experiencing "Off" EpisodesBy PR NewswireApr 27, 2020 7:30 AM EDT
PRESS RELEASESNeurocrine Biosciences Announces Conference Call And Webcast Of First Quarter 2020 Financial ResultsBy PR NewswireApr 15, 2020 4:01 PM EDT
PRESS RELEASESNeurocrine Biosciences Provides COVID-19 Business UpdateBy PR NewswireApr 3, 2020 8:30 AM EDT
PRESS RELEASESNeurocrine Biosciences To Present At Cowen 40th Annual Health Care ConferenceBy PR NewswireFeb 25, 2020 4:01 PM EST
PRESS RELEASESNeurocrine Biosciences Announces Appointment Of Shalini Sharp To Board Of DirectorsBy PR NewswireFeb 3, 2020 5:00 PM EST
PRESS RELEASESNeurocrine Biosciences Announces Conference Call And Webcast Of Fourth Quarter And Year-End 2019 Financial ResultsBy PR NewswireJan 20, 2020 4:30 PM EST
PRESS RELEASESNeurocrine Biosciences Provides Preliminary Fourth Quarter And Full-Year 2019 Net Product Sales Results And 2020 Program MilestonesBy PR NewswireJan 12, 2020 6:30 PM EST
PRESS RELEASESNeurocrine Biosciences And Idorsia Amend Option Agreement To License Novel Treatment For Rare Pediatric EpilepsyBy PR NewswireJan 9, 2020 8:00 PM EST
PRESS RELEASESNeurocrine Biosciences To Present At The 38th Annual J.P. Morgan Healthcare Conference Live Audio Webcast Will Be On January 13, 2020By PR NewswireJan 6, 2020 4:01 PM EST
OPINIONTuesday Investor Blog: Is the Bull Market in Stocks Being Ripped to Shreds?By Brian SozziMar 20, 2018 4:43 PM EDT
STOCKS15 Biotech Firms That Have Strong Potential to Be Acquired: JefferiesBy Kinsey GrantMar 20, 2018 2:58 PM EDT
